Bionano Genomics Inc
NASDAQ:BNGO

Watchlist Manager
Bionano Genomics Inc Logo
Bionano Genomics Inc
NASDAQ:BNGO
Watchlist
Price: 1.6 USD -0.62% Market Closed
Market Cap: 16.3m USD

Wall Street
Price Targets

BNGO Price Targets Summary
Bionano Genomics Inc

Wall Street analysts forecast BNGO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BNGO is 7.65 USD with a low forecast of 7.07 USD and a high forecast of 8.4 USD.

Lowest
Price Target
7.07 USD
342% Upside
Average
Price Target
7.65 USD
378% Upside
Highest
Price Target
8.4 USD
425% Upside
Bionano Genomics Inc Competitors:
Price Targets
GUBRA
Gubra A/S
22% Upside
RVTY
Revvity Inc
12% Upside
NANOFH
Nanoform Finland Oyj
189% Upside
688315
Novogene Co Ltd
16% Upside
MEDP
Medpace Holdings Inc
10% Downside
DIVISLAB
Divi's Laboratories Ltd
3% Upside
CRL
Charles River Laboratories International Inc
7% Downside
BANB
Bachem Holding AG
23% Upside

Revenue
Forecast

Revenue Estimate
Bionano Genomics Inc

For the last 7 years the compound annual growth rate for Bionano Genomics Inc's revenue is 18%. The projected CAGR for the next 4 years is 21%.

18%
Past Growth
21%
Estimated Growth
Estimates Accuracy
2%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Bionano Genomics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
Bionano Genomics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-95%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BNGO's stock price target?
Price Target
7.65 USD

According to Wall Street analysts, the average 1-year price target for BNGO is 7.65 USD with a low forecast of 7.07 USD and a high forecast of 8.4 USD.

What is Bionano Genomics Inc's Revenue forecast?
Projected CAGR
21%

For the last 7 years the compound annual growth rate for Bionano Genomics Inc's revenue is 18%. The projected CAGR for the next 4 years is 21%.

Back to Top